Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Deciphering antiviral efficacy of malaria box compounds against malaria exacerbating viral pathogens- Epstein Barr virus and SARS-CoV-2, an in silico study

9 Nov 2022

Abstract excerpt

In malaria endemic countries, coinfections and cotransmissions of different viral pathogens are widely reported. Prior studies have shown that malaria can trigger the Epstein-Barr virus (EBV) reactivation in the body. Besides, the altered immunity due to malaria could increase susceptibility to acquire co-circulating viruses like SARS-CoV-2 or vice versa during pandemic times. The dual burden of pathogens can...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diverse Scientific Research Studies
Share to Malaria Research and Control
Share to Mosquito-borne diseases and control

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36415887
DOI: 10.1016/j.medidd.2022.100146

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Deciphering antiviral efficacy of malaria box compounds against malaria exacerbating viral pathogens- Epstein Barr virus and SARS-CoV-2, an in silico studyPMID 36415887Read ↗

Attacking the SARS-CoV-2 Replication Machinery with the Pathogen Box’s MoleculesSemantic proximity Read ↗

Driving antimalarial design through understanding of target mechanism.Semantic proximity Read ↗

Screening the Medicines for Malaria Venture Pathogen Box for invasion and egress inhibitors of the blood stage of <i>Plasmodium falciparum</i> reveals several inhibitory compoundsSemantic proximity Read ↗

Exploring Chemical Space to Identify Partial Binders Against hMPV Nucleocapsid ProteinSemantic proximity Read ↗

Novel antimalarial drug targets: hope for new antimalarial drugsSemantic proximity Read ↗

Integrated Docking and Enhanced Sampling Based Selection of Repurposing Drugs for SARS-CoV-2 by Targeting Host Dependent FactorsSemantic proximity Read ↗

An extensive computational approach to inhibit MSP-1 of <i>P.vivax</i> elucidates further horizon in the establishment next generation therapeutics against malariaSemantic proximity Read ↗

Whole-genome and mitogenome based in silico analysis of select <i>Plasmodium</i> and identification of a novel drug molecule against the malaria parasiteSemantic proximity Read ↗

Identifying host regulators and inhibitors of liver stage malaria infection using kinase activity profilesSemantic proximity Read ↗

A multiscale in silico approach to impede the interaction between Dengue NS1 and Human RPL18, aiming to suppress the Dengue viral translation and proliferationSemantic proximity Read ↗

In vitro antimalarial activity and molecular modeling studies of novel artemisinin derivativesSemantic proximity Read ↗

Pathogen Box screening for hit identification against Mycobacterium abscessusSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.